Global Pharmaceutical CXO Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 146
Published Date: 11 Jan 2024
Category: Service & Software
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Pharmaceutical CXO market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
CXO is a pharmaceutical contract outsourcing service, which mainly includes pharmaceutical contract research and development services (CRO) and pharmaceutical contract manufacturing services (CDMO) and CMO.
In the process of new drug development, through pharmaceutical contract outsourcing, pharmaceutical companies or biotechnology companies commission drug R&D and production companies to provide professional R&D services, including technical process development, API and CCMO production, formulation production, etc.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pharmaceutical CXO industry chain, the market status of Pharmaceutical Companies (CRO, CMO), Biotechnology Companies (CRO, CMO), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmaceutical CXO.
Regionally, the report analyzes the Pharmaceutical CXO markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmaceutical CXO market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmaceutical CXO market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmaceutical CXO industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., CRO, CMO).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmaceutical CXO market.
Regional Analysis: The report involves examining the Pharmaceutical CXO market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmaceutical CXO market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmaceutical CXO:
Company Analysis: Report covers individual Pharmaceutical CXO players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmaceutical CXO This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical Companies, Biotechnology Companies).
Technology Analysis: Report covers specific technologies relevant to Pharmaceutical CXO. It assesses the current state, advancements, and potential future developments in Pharmaceutical CXO areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmaceutical CXO market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pharmaceutical CXO market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
CRO
CMO
CDMO
Market segment by Application
Pharmaceutical Companies
Biotechnology Companies
Market segment by players, this report covers
WuXi AppTec
Tigermed
Charles River Laboratories
Pharmaron Inc
Labcorp Drug Development
Boehringer Ingelheim
GenScript
MabPlex International
Shanghai ChemPartner
Wuxi Biologics
Pharmablock
Jiuzhou Pharma
Asym Chemical
IQVIA
Syneos Health
Parexel
AGC Biologics
FUJIFILM Diosynth Biotechnologies
Patheon
Catalent
Lonza Group AG
Avid Bioservices
AbbVie
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmaceutical CXO product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmaceutical CXO, with revenue, gross margin and global market share of Pharmaceutical CXO from 2019 to 2024.
Chapter 3, the Pharmaceutical CXO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharmaceutical CXO market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmaceutical CXO.
Chapter 13, to describe Pharmaceutical CXO research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Pharmaceutical CXO
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Pharmaceutical CXO by Type
1.3.1 Overview: Global Pharmaceutical CXO Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Pharmaceutical CXO Consumption Value Market Share by Type in 2023
1.3.3 CRO
1.3.4 CMO
1.3.5 CDMO
1.4 Global Pharmaceutical CXO Market by Application
1.4.1 Overview: Global Pharmaceutical CXO Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical Companies
1.4.3 Biotechnology Companies
1.5 Global Pharmaceutical CXO Market Size & Forecast
1.6 Global Pharmaceutical CXO Market Size and Forecast by Region
1.6.1 Global Pharmaceutical CXO Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Pharmaceutical CXO Market Size by Region, (2019-2030)
1.6.3 North America Pharmaceutical CXO Market Size and Prospect (2019-2030)
1.6.4 Europe Pharmaceutical CXO Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Pharmaceutical CXO Market Size and Prospect (2019-2030)
1.6.6 South America Pharmaceutical CXO Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Pharmaceutical CXO Market Size and Prospect (2019-2030)
2.1 WuXi AppTec
2.1.1 WuXi AppTec Details
2.1.2 WuXi AppTec Major Business
2.1.3 WuXi AppTec Pharmaceutical CXO Product and Solutions
2.1.4 WuXi AppTec Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 WuXi AppTec Recent Developments and Future Plans
2.2 Tigermed
2.2.1 Tigermed Details
2.2.2 Tigermed Major Business
2.2.3 Tigermed Pharmaceutical CXO Product and Solutions
2.2.4 Tigermed Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Tigermed Recent Developments and Future Plans
2.3 Charles River Laboratories
2.3.1 Charles River Laboratories Details
2.3.2 Charles River Laboratories Major Business
2.3.3 Charles River Laboratories Pharmaceutical CXO Product and Solutions
2.3.4 Charles River Laboratories Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Charles River Laboratories Recent Developments and Future Plans
2.4 Pharmaron Inc
2.4.1 Pharmaron Inc Details
2.4.2 Pharmaron Inc Major Business
2.4.3 Pharmaron Inc Pharmaceutical CXO Product and Solutions
2.4.4 Pharmaron Inc Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pharmaron Inc Recent Developments and Future Plans
2.5 Labcorp Drug Development
2.5.1 Labcorp Drug Development Details
2.5.2 Labcorp Drug Development Major Business
2.5.3 Labcorp Drug Development Pharmaceutical CXO Product and Solutions
2.5.4 Labcorp Drug Development Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Labcorp Drug Development Recent Developments and Future Plans
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Pharmaceutical CXO Product and Solutions
2.6.4 Boehringer Ingelheim Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Boehringer Ingelheim Recent Developments and Future Plans
2.7 GenScript
2.7.1 GenScript Details
2.7.2 GenScript Major Business
2.7.3 GenScript Pharmaceutical CXO Product and Solutions
2.7.4 GenScript Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 GenScript Recent Developments and Future Plans
2.8 MabPlex International
2.8.1 MabPlex International Details
2.8.2 MabPlex International Major Business
2.8.3 MabPlex International Pharmaceutical CXO Product and Solutions
2.8.4 MabPlex International Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 MabPlex International Recent Developments and Future Plans
2.9 Shanghai ChemPartner
2.9.1 Shanghai ChemPartner Details
2.9.2 Shanghai ChemPartner Major Business
2.9.3 Shanghai ChemPartner Pharmaceutical CXO Product and Solutions
2.9.4 Shanghai ChemPartner Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Shanghai ChemPartner Recent Developments and Future Plans
2.10 Wuxi Biologics
2.10.1 Wuxi Biologics Details
2.10.2 Wuxi Biologics Major Business
2.10.3 Wuxi Biologics Pharmaceutical CXO Product and Solutions
2.10.4 Wuxi Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Wuxi Biologics Recent Developments and Future Plans
2.11 Pharmablock
2.11.1 Pharmablock Details
2.11.2 Pharmablock Major Business
2.11.3 Pharmablock Pharmaceutical CXO Product and Solutions
2.11.4 Pharmablock Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Pharmablock Recent Developments and Future Plans
2.12 Jiuzhou Pharma
2.12.1 Jiuzhou Pharma Details
2.12.2 Jiuzhou Pharma Major Business
2.12.3 Jiuzhou Pharma Pharmaceutical CXO Product and Solutions
2.12.4 Jiuzhou Pharma Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Jiuzhou Pharma Recent Developments and Future Plans
2.13 Asym Chemical
2.13.1 Asym Chemical Details
2.13.2 Asym Chemical Major Business
2.13.3 Asym Chemical Pharmaceutical CXO Product and Solutions
2.13.4 Asym Chemical Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Asym Chemical Recent Developments and Future Plans
2.14 IQVIA
2.14.1 IQVIA Details
2.14.2 IQVIA Major Business
2.14.3 IQVIA Pharmaceutical CXO Product and Solutions
2.14.4 IQVIA Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 IQVIA Recent Developments and Future Plans
2.15 Syneos Health
2.15.1 Syneos Health Details
2.15.2 Syneos Health Major Business
2.15.3 Syneos Health Pharmaceutical CXO Product and Solutions
2.15.4 Syneos Health Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Syneos Health Recent Developments and Future Plans
2.16 Parexel
2.16.1 Parexel Details
2.16.2 Parexel Major Business
2.16.3 Parexel Pharmaceutical CXO Product and Solutions
2.16.4 Parexel Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Parexel Recent Developments and Future Plans
2.17 AGC Biologics
2.17.1 AGC Biologics Details
2.17.2 AGC Biologics Major Business
2.17.3 AGC Biologics Pharmaceutical CXO Product and Solutions
2.17.4 AGC Biologics Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 AGC Biologics Recent Developments and Future Plans
2.18 FUJIFILM Diosynth Biotechnologies
2.18.1 FUJIFILM Diosynth Biotechnologies Details
2.18.2 FUJIFILM Diosynth Biotechnologies Major Business
2.18.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product and Solutions
2.18.4 FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.19 Patheon
2.19.1 Patheon Details
2.19.2 Patheon Major Business
2.19.3 Patheon Pharmaceutical CXO Product and Solutions
2.19.4 Patheon Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Patheon Recent Developments and Future Plans
2.20 Catalent
2.20.1 Catalent Details
2.20.2 Catalent Major Business
2.20.3 Catalent Pharmaceutical CXO Product and Solutions
2.20.4 Catalent Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Catalent Recent Developments and Future Plans
2.21 Lonza Group AG
2.21.1 Lonza Group AG Details
2.21.2 Lonza Group AG Major Business
2.21.3 Lonza Group AG Pharmaceutical CXO Product and Solutions
2.21.4 Lonza Group AG Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Lonza Group AG Recent Developments and Future Plans
2.22 Avid Bioservices
2.22.1 Avid Bioservices Details
2.22.2 Avid Bioservices Major Business
2.22.3 Avid Bioservices Pharmaceutical CXO Product and Solutions
2.22.4 Avid Bioservices Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Avid Bioservices Recent Developments and Future Plans
2.23 AbbVie
2.23.1 AbbVie Details
2.23.2 AbbVie Major Business
2.23.3 AbbVie Pharmaceutical CXO Product and Solutions
2.23.4 AbbVie Pharmaceutical CXO Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 AbbVie Recent Developments and Future Plans
3.1 Global Pharmaceutical CXO Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Pharmaceutical CXO by Company Revenue
3.2.2 Top 3 Pharmaceutical CXO Players Market Share in 2023
3.2.3 Top 6 Pharmaceutical CXO Players Market Share in 2023
3.3 Pharmaceutical CXO Market: Overall Company Footprint Analysis
3.3.1 Pharmaceutical CXO Market: Region Footprint
3.3.2 Pharmaceutical CXO Market: Company Product Type Footprint
3.3.3 Pharmaceutical CXO Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Pharmaceutical CXO Consumption Value and Market Share by Type (2019-2024)
4.2 Global Pharmaceutical CXO Market Forecast by Type (2025-2030)
5.1 Global Pharmaceutical CXO Consumption Value Market Share by Application (2019-2024)
5.2 Global Pharmaceutical CXO Market Forecast by Application (2025-2030)
6.1 North America Pharmaceutical CXO Consumption Value by Type (2019-2030)
6.2 North America Pharmaceutical CXO Consumption Value by Application (2019-2030)
6.3 North America Pharmaceutical CXO Market Size by Country
6.3.1 North America Pharmaceutical CXO Consumption Value by Country (2019-2030)
6.3.2 United States Pharmaceutical CXO Market Size and Forecast (2019-2030)
6.3.3 Canada Pharmaceutical CXO Market Size and Forecast (2019-2030)
6.3.4 Mexico Pharmaceutical CXO Market Size and Forecast (2019-2030)
7.1 Europe Pharmaceutical CXO Consumption Value by Type (2019-2030)
7.2 Europe Pharmaceutical CXO Consumption Value by Application (2019-2030)
7.3 Europe Pharmaceutical CXO Market Size by Country
7.3.1 Europe Pharmaceutical CXO Consumption Value by Country (2019-2030)
7.3.2 Germany Pharmaceutical CXO Market Size and Forecast (2019-2030)
7.3.3 France Pharmaceutical CXO Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Pharmaceutical CXO Market Size and Forecast (2019-2030)
7.3.5 Russia Pharmaceutical CXO Market Size and Forecast (2019-2030)
7.3.6 Italy Pharmaceutical CXO Market Size and Forecast (2019-2030)
8.1 Asia-Pacific Pharmaceutical CXO Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Pharmaceutical CXO Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Pharmaceutical CXO Market Size by Region
8.3.1 Asia-Pacific Pharmaceutical CXO Consumption Value by Region (2019-2030)
8.3.2 China Pharmaceutical CXO Market Size and Forecast (2019-2030)
8.3.3 Japan Pharmaceutical CXO Market Size and Forecast (2019-2030)
8.3.4 South Korea Pharmaceutical CXO Market Size and Forecast (2019-2030)
8.3.5 India Pharmaceutical CXO Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Pharmaceutical CXO Market Size and Forecast (2019-2030)
8.3.7 Australia Pharmaceutical CXO Market Size and Forecast (2019-2030)
9.1 South America Pharmaceutical CXO Consumption Value by Type (2019-2030)
9.2 South America Pharmaceutical CXO Consumption Value by Application (2019-2030)
9.3 South America Pharmaceutical CXO Market Size by Country
9.3.1 South America Pharmaceutical CXO Consumption Value by Country (2019-2030)
9.3.2 Brazil Pharmaceutical CXO Market Size and Forecast (2019-2030)
9.3.3 Argentina Pharmaceutical CXO Market Size and Forecast (2019-2030)
10.1 Middle East & Africa Pharmaceutical CXO Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Pharmaceutical CXO Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Pharmaceutical CXO Market Size by Country
10.3.1 Middle East & Africa Pharmaceutical CXO Consumption Value by Country (2019-2030)
10.3.2 Turkey Pharmaceutical CXO Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Pharmaceutical CXO Market Size and Forecast (2019-2030)
10.3.4 UAE Pharmaceutical CXO Market Size and Forecast (2019-2030)
11.1 Pharmaceutical CXO Market Drivers
11.2 Pharmaceutical CXO Market Restraints
11.3 Pharmaceutical CXO Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 Pharmaceutical CXO Industry Chain
12.2 Pharmaceutical CXO Upstream Analysis
12.3 Pharmaceutical CXO Midstream Analysis
12.4 Pharmaceutical CXO Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pharmaceutical CXO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pharmaceutical CXO Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Pharmaceutical CXO Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Pharmaceutical CXO Consumption Value by Region (2025-2030) & (USD Million)
Table 5. WuXi AppTec Company Information, Head Office, and Major Competitors
Table 6. WuXi AppTec Major Business
Table 7. WuXi AppTec Pharmaceutical CXO Product and Solutions
Table 8. WuXi AppTec Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. WuXi AppTec Recent Developments and Future Plans
Table 10. Tigermed Company Information, Head Office, and Major Competitors
Table 11. Tigermed Major Business
Table 12. Tigermed Pharmaceutical CXO Product and Solutions
Table 13. Tigermed Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Tigermed Recent Developments and Future Plans
Table 15. Charles River Laboratories Company Information, Head Office, and Major Competitors
Table 16. Charles River Laboratories Major Business
Table 17. Charles River Laboratories Pharmaceutical CXO Product and Solutions
Table 18. Charles River Laboratories Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Charles River Laboratories Recent Developments and Future Plans
Table 20. Pharmaron Inc Company Information, Head Office, and Major Competitors
Table 21. Pharmaron Inc Major Business
Table 22. Pharmaron Inc Pharmaceutical CXO Product and Solutions
Table 23. Pharmaron Inc Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Pharmaron Inc Recent Developments and Future Plans
Table 25. Labcorp Drug Development Company Information, Head Office, and Major Competitors
Table 26. Labcorp Drug Development Major Business
Table 27. Labcorp Drug Development Pharmaceutical CXO Product and Solutions
Table 28. Labcorp Drug Development Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Labcorp Drug Development Recent Developments and Future Plans
Table 30. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 31. Boehringer Ingelheim Major Business
Table 32. Boehringer Ingelheim Pharmaceutical CXO Product and Solutions
Table 33. Boehringer Ingelheim Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Boehringer Ingelheim Recent Developments and Future Plans
Table 35. GenScript Company Information, Head Office, and Major Competitors
Table 36. GenScript Major Business
Table 37. GenScript Pharmaceutical CXO Product and Solutions
Table 38. GenScript Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. GenScript Recent Developments and Future Plans
Table 40. MabPlex International Company Information, Head Office, and Major Competitors
Table 41. MabPlex International Major Business
Table 42. MabPlex International Pharmaceutical CXO Product and Solutions
Table 43. MabPlex International Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. MabPlex International Recent Developments and Future Plans
Table 45. Shanghai ChemPartner Company Information, Head Office, and Major Competitors
Table 46. Shanghai ChemPartner Major Business
Table 47. Shanghai ChemPartner Pharmaceutical CXO Product and Solutions
Table 48. Shanghai ChemPartner Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Shanghai ChemPartner Recent Developments and Future Plans
Table 50. Wuxi Biologics Company Information, Head Office, and Major Competitors
Table 51. Wuxi Biologics Major Business
Table 52. Wuxi Biologics Pharmaceutical CXO Product and Solutions
Table 53. Wuxi Biologics Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Wuxi Biologics Recent Developments and Future Plans
Table 55. Pharmablock Company Information, Head Office, and Major Competitors
Table 56. Pharmablock Major Business
Table 57. Pharmablock Pharmaceutical CXO Product and Solutions
Table 58. Pharmablock Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Pharmablock Recent Developments and Future Plans
Table 60. Jiuzhou Pharma Company Information, Head Office, and Major Competitors
Table 61. Jiuzhou Pharma Major Business
Table 62. Jiuzhou Pharma Pharmaceutical CXO Product and Solutions
Table 63. Jiuzhou Pharma Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Jiuzhou Pharma Recent Developments and Future Plans
Table 65. Asym Chemical Company Information, Head Office, and Major Competitors
Table 66. Asym Chemical Major Business
Table 67. Asym Chemical Pharmaceutical CXO Product and Solutions
Table 68. Asym Chemical Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Asym Chemical Recent Developments and Future Plans
Table 70. IQVIA Company Information, Head Office, and Major Competitors
Table 71. IQVIA Major Business
Table 72. IQVIA Pharmaceutical CXO Product and Solutions
Table 73. IQVIA Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. IQVIA Recent Developments and Future Plans
Table 75. Syneos Health Company Information, Head Office, and Major Competitors
Table 76. Syneos Health Major Business
Table 77. Syneos Health Pharmaceutical CXO Product and Solutions
Table 78. Syneos Health Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Syneos Health Recent Developments and Future Plans
Table 80. Parexel Company Information, Head Office, and Major Competitors
Table 81. Parexel Major Business
Table 82. Parexel Pharmaceutical CXO Product and Solutions
Table 83. Parexel Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Parexel Recent Developments and Future Plans
Table 85. AGC Biologics Company Information, Head Office, and Major Competitors
Table 86. AGC Biologics Major Business
Table 87. AGC Biologics Pharmaceutical CXO Product and Solutions
Table 88. AGC Biologics Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. AGC Biologics Recent Developments and Future Plans
Table 90. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 91. FUJIFILM Diosynth Biotechnologies Major Business
Table 92. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Product and Solutions
Table 93. FUJIFILM Diosynth Biotechnologies Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 95. Patheon Company Information, Head Office, and Major Competitors
Table 96. Patheon Major Business
Table 97. Patheon Pharmaceutical CXO Product and Solutions
Table 98. Patheon Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 99. Patheon Recent Developments and Future Plans
Table 100. Catalent Company Information, Head Office, and Major Competitors
Table 101. Catalent Major Business
Table 102. Catalent Pharmaceutical CXO Product and Solutions
Table 103. Catalent Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 104. Catalent Recent Developments and Future Plans
Table 105. Lonza Group AG Company Information, Head Office, and Major Competitors
Table 106. Lonza Group AG Major Business
Table 107. Lonza Group AG Pharmaceutical CXO Product and Solutions
Table 108. Lonza Group AG Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 109. Lonza Group AG Recent Developments and Future Plans
Table 110. Avid Bioservices Company Information, Head Office, and Major Competitors
Table 111. Avid Bioservices Major Business
Table 112. Avid Bioservices Pharmaceutical CXO Product and Solutions
Table 113. Avid Bioservices Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 114. Avid Bioservices Recent Developments and Future Plans
Table 115. AbbVie Company Information, Head Office, and Major Competitors
Table 116. AbbVie Major Business
Table 117. AbbVie Pharmaceutical CXO Product and Solutions
Table 118. AbbVie Pharmaceutical CXO Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. AbbVie Recent Developments and Future Plans
Table 120. Global Pharmaceutical CXO Revenue (USD Million) by Players (2019-2024)
Table 121. Global Pharmaceutical CXO Revenue Share by Players (2019-2024)
Table 122. Breakdown of Pharmaceutical CXO by Company Type (Tier 1, Tier 2, and Tier 3)
Table 123. Market Position of Players in Pharmaceutical CXO, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 124. Head Office of Key Pharmaceutical CXO Players
Table 125. Pharmaceutical CXO Market: Company Product Type Footprint
Table 126. Pharmaceutical CXO Market: Company Product Application Footprint
Table 127. Pharmaceutical CXO New Market Entrants and Barriers to Market Entry
Table 128. Pharmaceutical CXO Mergers, Acquisition, Agreements, and Collaborations
Table 129. Global Pharmaceutical CXO Consumption Value (USD Million) by Type (2019-2024)
Table 130. Global Pharmaceutical CXO Consumption Value Share by Type (2019-2024)
Table 131. Global Pharmaceutical CXO Consumption Value Forecast by Type (2025-2030)
Table 132. Global Pharmaceutical CXO Consumption Value by Application (2019-2024)
Table 133. Global Pharmaceutical CXO Consumption Value Forecast by Application (2025-2030)
Table 134. North America Pharmaceutical CXO Consumption Value by Type (2019-2024) & (USD Million)
Table 135. North America Pharmaceutical CXO Consumption Value by Type (2025-2030) & (USD Million)
Table 136. North America Pharmaceutical CXO Consumption Value by Application (2019-2024) & (USD Million)
Table 137. North America Pharmaceutical CXO Consumption Value by Application (2025-2030) & (USD Million)
Table 138. North America Pharmaceutical CXO Consumption Value by Country (2019-2024) & (USD Million)
Table 139. North America Pharmaceutical CXO Consumption Value by Country (2025-2030) & (USD Million)
Table 140. Europe Pharmaceutical CXO Consumption Value by Type (2019-2024) & (USD Million)
Table 141. Europe Pharmaceutical CXO Consumption Value by Type (2025-2030) & (USD Million)
Table 142. Europe Pharmaceutical CXO Consumption Value by Application (2019-2024) & (USD Million)
Table 143. Europe Pharmaceutical CXO Consumption Value by Application (2025-2030) & (USD Million)
Table 144. Europe Pharmaceutical CXO Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Pharmaceutical CXO Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Pharmaceutical CXO Consumption Value by Type (2019-2024) & (USD Million)
Table 147. Asia-Pacific Pharmaceutical CXO Consumption Value by Type (2025-2030) & (USD Million)
Table 148. Asia-Pacific Pharmaceutical CXO Consumption Value by Application (2019-2024) & (USD Million)
Table 149. Asia-Pacific Pharmaceutical CXO Consumption Value by Application (2025-2030) & (USD Million)
Table 150. Asia-Pacific Pharmaceutical CXO Consumption Value by Region (2019-2024) & (USD Million)
Table 151. Asia-Pacific Pharmaceutical CXO Consumption Value by Region (2025-2030) & (USD Million)
Table 152. South America Pharmaceutical CXO Consumption Value by Type (2019-2024) & (USD Million)
Table 153. South America Pharmaceutical CXO Consumption Value by Type (2025-2030) & (USD Million)
Table 154. South America Pharmaceutical CXO Consumption Value by Application (2019-2024) & (USD Million)
Table 155. South America Pharmaceutical CXO Consumption Value by Application (2025-2030) & (USD Million)
Table 156. South America Pharmaceutical CXO Consumption Value by Country (2019-2024) & (USD Million)
Table 157. South America Pharmaceutical CXO Consumption Value by Country (2025-2030) & (USD Million)
Table 158. Middle East & Africa Pharmaceutical CXO Consumption Value by Type (2019-2024) & (USD Million)
Table 159. Middle East & Africa Pharmaceutical CXO Consumption Value by Type (2025-2030) & (USD Million)
Table 160. Middle East & Africa Pharmaceutical CXO Consumption Value by Application (2019-2024) & (USD Million)
Table 161. Middle East & Africa Pharmaceutical CXO Consumption Value by Application (2025-2030) & (USD Million)
Table 162. Middle East & Africa Pharmaceutical CXO Consumption Value by Country (2019-2024) & (USD Million)
Table 163. Middle East & Africa Pharmaceutical CXO Consumption Value by Country (2025-2030) & (USD Million)
Table 164. Pharmaceutical CXO Raw Material
Table 165. Key Suppliers of Pharmaceutical CXO Raw Materials
List of Figures
Figure 1. Pharmaceutical CXO Picture
Figure 2. Global Pharmaceutical CXO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pharmaceutical CXO Consumption Value Market Share by Type in 2023
Figure 4. CRO
Figure 5. CMO
Figure 6. CDMO
Figure 7. Global Pharmaceutical CXO Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Pharmaceutical CXO Consumption Value Market Share by Application in 2023
Figure 9. Pharmaceutical Companies Picture
Figure 10. Biotechnology Companies Picture
Figure 11. Global Pharmaceutical CXO Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Pharmaceutical CXO Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market Pharmaceutical CXO Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global Pharmaceutical CXO Consumption Value Market Share by Region (2019-2030)
Figure 15. Global Pharmaceutical CXO Consumption Value Market Share by Region in 2023
Figure 16. North America Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 19. South America Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 21. Global Pharmaceutical CXO Revenue Share by Players in 2023
Figure 22. Pharmaceutical CXO Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players Pharmaceutical CXO Market Share in 2023
Figure 24. Global Top 6 Players Pharmaceutical CXO Market Share in 2023
Figure 25. Global Pharmaceutical CXO Consumption Value Share by Type (2019-2024)
Figure 26. Global Pharmaceutical CXO Market Share Forecast by Type (2025-2030)
Figure 27. Global Pharmaceutical CXO Consumption Value Share by Application (2019-2024)
Figure 28. Global Pharmaceutical CXO Market Share Forecast by Application (2025-2030)
Figure 29. North America Pharmaceutical CXO Consumption Value Market Share by Type (2019-2030)
Figure 30. North America Pharmaceutical CXO Consumption Value Market Share by Application (2019-2030)
Figure 31. North America Pharmaceutical CXO Consumption Value Market Share by Country (2019-2030)
Figure 32. United States Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe Pharmaceutical CXO Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe Pharmaceutical CXO Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe Pharmaceutical CXO Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 39. France Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific Pharmaceutical CXO Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific Pharmaceutical CXO Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific Pharmaceutical CXO Consumption Value Market Share by Region (2019-2030)
Figure 46. China Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 49. India Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 52. South America Pharmaceutical CXO Consumption Value Market Share by Type (2019-2030)
Figure 53. South America Pharmaceutical CXO Consumption Value Market Share by Application (2019-2030)
Figure 54. South America Pharmaceutical CXO Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa Pharmaceutical CXO Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa Pharmaceutical CXO Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa Pharmaceutical CXO Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE Pharmaceutical CXO Consumption Value (2019-2030) & (USD Million)
Figure 63. Pharmaceutical CXO Market Drivers
Figure 64. Pharmaceutical CXO Market Restraints
Figure 65. Pharmaceutical CXO Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Pharmaceutical CXO in 2023
Figure 68. Manufacturing Process Analysis of Pharmaceutical CXO
Figure 69. Pharmaceutical CXO Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
WuXi AppTec Tigermed Charles River Laboratories Pharmaron Inc Labcorp Drug Development Boehringer Ingelheim GenScript MabPlex International Shanghai ChemPartner Wuxi Biologics Pharmablock Jiuzhou Pharma Asym Chemical IQVIA Syneos Health Parexel AGC Biologics FUJIFILM Diosynth Biotechnologies Patheon Catalent Lonza Group AG Avid Bioservices AbbVie
Related Reports
25 Sep 2023
Service & Software
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
